- In a regulatory filing, Capstone Therapeutics (OTC:CAPS) discloses that its auditor, Moss Adams LLP, has resigned after the company notified it that it could not authorize the audit for its 10-K financial statements because it needs to conserve cash for operations.
Capstone's auditor bids adieu
Recommended For You
More Trending News
About CAPS Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| CAPS | - | - |
| Capstone Holding Corp. | ||